China Literature Limited (abbreviated “CHINA LIT”) disclosed that it repurchased 400,000 ordinary shares on 25 August 2026 via on-market transactions on the Hong Kong Stock Exchange.

The purchase price ranged between HKD 19.51 and HKD 20.98 per share, with a volume-weighted average cost of HKD 20.58. The total consideration amounted to HKD 8.23 million, and the shares represent 0.0393 % of the company’s 1.02 billion issued shares (excluding treasury shares) outstanding prior to the transaction. The repurchased shares are earmarked for cancellation and therefore remain in issued share capital until cancellation is completed.

Including this latest transaction, CHINA LIT has repurchased 1.60 million shares between 20 and 25 August 2026 at average unit prices of HKD 20.23, HKD 19.85, HKD 19.59 and HKD 20.58, respectively. These four repurchases collectively account for approximately 0.16 % of the company’s issued share base.

Since shareholders approved the current buyback mandate on 2 June 2026, the company has repurchased a cumulative 12.18 million shares, equivalent to 1.19 % of the shares in issue on the mandate date. The authorised limit under the mandate stands at 102.15 million shares, leaving roughly 89.97 million shares, or 88 % of the mandate, still available for potential repurchase.

Under Hong Kong listing regulations, CHINA LIT is subject to a moratorium on new share issuance or treasury-share disposal until 24 September 2026 following the recent repurchases.